{"product_id":"uscap-gynecologic-pathology-masterclass-contemporary-issues-in-light-of-shifting-nomenclature-criteria-and-ancillary-testing-2026","title":"USCAP Gynecologic Pathology Masterclass Contemporary Issues in Light of Shifting Nomenclature, Criteria, and Ancillary Testing 2026","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos + file sub vtt +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: practicing academic and community pathologists, and pathologists-in-training\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eOriginal release date: July 1, 2026\u003c\/p\u003e\n\u003cp\u003eJoin expert faculty as they discuss the significant updates occurring in the field of gynecologic pathology. With the upcoming release of the 6th edition of the World Health Organization (WHO) Classification of Tumours of Female Reproductive Organs, and updates to other established diagnostic and staging frameworks, such as FIGO, the International Collaboration on Cancer Reporting (ICCR), and NCCN guidelines, now is the time for an in-depth course to keep your practice up to date. A thorough understanding of these advanced diagnostics is crucial for pathologists and clinicians. Trainees and practicing pathologists alike will need to familiarize themselves with new terminology, recognize newly characterized entities, and adapt to the evolving criteria that may influence patient management. New resources increasingly incorporate molecular markers and biomarker testing to refine risk stratification, prognostication, and targeted therapies, contributing to the trend toward precision medicine in gynecologic oncology. Participants will learn to utilize key resources, interpret changes in classification, recognize scenarios requiring molecular diagnostics, and integrate biomarker data into clinical decision-making.\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003ePracticing academic and community pathologists, and pathologists-in-training\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this educational activity, learners will be able to:\u003c\/h3\u003e\n\u003cp\u003eUnderstand and apply in daily practice essential resources, including the upcoming WHO classification of tumours of the female reproductive system, the most recent updates to the FIGO staging systems, ICCR resources, and current NCCN guidelines for the management of patients with gynecologic cancer.\u003c\/p\u003e\n\u003cp\u003eAppraise emerging information on clinically relevant forms of endometrial, upper genital and mesenchymal gynecologic neoplasia.\u003c\/p\u003e\n\u003cp\u003eDescribe the novel classification systems for lower genital tract neoplasia including the currently recommended nomenclature.\u003c\/p\u003e\n\u003cp\u003eIdentify the scenarios in which diagnosis of non-epithelial (mesenchymal, sex-cord stromal, gestational) gynecologic neoplasia, as per WHO criteria, requires molecular testing as an essential criterion, and how to proceed when such testing is not available.\u003c\/p\u003e\n\u003cp\u003eDiscuss the role of biomarker testing in the diagnosis, prognosis and management of patients with ovarian cancer, endometrial cancer and cervical cancer.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003ePathology of Ovarian Epithelial Tumors – C. Blake Gilks, MD\u003c\/p\u003e\n\u003cp\u003eMolecular Testing in Ovarian Cancer – Ian S. Hagemann, MD, PhD\u003c\/p\u003e\n\u003cp\u003eEndometrial Pathology – Charles “Matt” Quick, MD\u003c\/p\u003e\n\u003cp\u003eMolecular Testing in Endometrial Cancer – Ian S. Hagemann, MD, PhD\u003c\/p\u003e\n\u003cp\u003eEndometrium – Charles “Matt” Quick, MD\u003c\/p\u003e\n\u003cp\u003eMolecular Testing in Mesenchymal and Gestational Trophoblastic Lesions – Ian S. Hagemann, MD, PhD\u003c\/p\u003e\n\u003cp\u003eBiomarker Testing in Lower Genital Tract Neoplasia – Ian S. Hagemann, MD, PhD\u003c\/p\u003e\n\u003cp\u003eOvarian Epithelial Lesions – C. Blake Gilks, MD\u003c\/p\u003e\n\u003cp\u003eOvarian Non-Epithelial Lesions – Marisa R. Nucci, MD\u003c\/p\u003e\n\u003cp\u003ePathology of Non-Epithelial Ovarian Tumors – Marisa R. Nucci, MD\u003c\/p\u003e\n\u003cp\u003eGynecologic Mesenchymal Neoplasia – Brooke E. Howitt, MD\u003c\/p\u003e\n\u003cp\u003eMesenchymal Neoplasms – Brooke E. Howitt, MD\u003c\/p\u003e\n\u003cp\u003eCervix – Carlos Parra-Herran, MD\u003c\/p\u003e\n\u003cp\u003ePathology of the Uterine Cervix – Carlos Parra-Herran, MD\u003c\/p\u003e\n\u003cp\u003eVulvo-Vaginal Pathology – Marilyn A. Kinloch, MD, FRCPC\u003c\/p\u003e\n\u003cp\u003eVulva – Marilyn A. Kinloch, MD, FRCPC\u003c\/p\u003e\n\u003cp\u003eRoundtable: Grey Areas in Endometrial Pathology\u003c\/p\u003e\n\u003cp\u003eRoundtable: Grey Areas in Ovarian Pathology\u003c\/p\u003e\n\u003cp\u003eRoundtable: Grey Areas in Non-Epithelial Gynecologic Neoplasia\u003c\/p\u003e\n\u003cp\u003eRoundtable: Grey Areas in Lower Genital Tract Pathology\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405757665476,"sku":null,"price":156.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/USCAP-Gynecologic-Pathology-Masterclass-Contemporary-Issues-in-Light-of-Shifting-Nomenclature-Criteria-and-Ancillary-Testing-2026.jpg?v=1784215793","url":"https:\/\/medicalcoursespro.com\/products\/uscap-gynecologic-pathology-masterclass-contemporary-issues-in-light-of-shifting-nomenclature-criteria-and-ancillary-testing-2026","provider":"Medicalcoursespro","version":"1.0","type":"link"}